Ultromics Granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis Detection
The platform uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosis
Source: dicardiology.com
Stay updated with breaking news from Ultromic Echogo Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The platform uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosis